Microbix’s Multiplex Quality Control for STI Diagnosis
STIs: A public health issue
Sexually transmitted infections (STIs) are a significant public health issue, with millions of new cases diagnosed each year. Accurate and timely diagnosis is crucial to prevent the spread of these infections and ensure that patients receive appropriate treatment. Multiplex CT/NG/TV/MGEN is a molecular diagnostic test that can detect several of the most common STIs, including Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Trichomonas vaginalis (TV), and Mycoplasma genitalium (MGEN). The test uses a polymerase chain reaction (PCR) technique to amplify and detect genetic material from these pathogens.
While multiplex CT/NG/TV/MGEN is a highly sensitive and specific test, it is not foolproof. False-positive and false-negative results can occur due to a variety of factors, such as sample contamination, inadequate sample collection, or issues with the test kit itself. These errors can lead to misdiagnosis and improper treatment, which can have serious consequences for patients.
To minimize the risk of diagnostic errors, it is essential to perform regular quality control testing on the multiplex CT/NG/TV/MGEN assay. This is where Microbix’s Multiplex Quality Control product comes in. The quality control product is designed to mimic patient samples, containing precisely measured amounts of CT, NG, TV, and MGEN DNA. The product is run alongside patient samples during testing, and the results are compared to ensure that the test is performing correctly.
Microbix is a leading biotechnology company that specializes in the development, manufacture, and distribution of infectious disease antigens and quality control products for the diagnostics industry. With a focus on improving patient outcomes, Microbix offers a range of products that help healthcare providers accurately diagnose and treat infectious diseases. One of the company’s top offerings is its Multiplex Quality Control: Multiplex CT/NG/TV/MGEN product, which helps to ensure the accuracy and reliability of diagnostic tests for several common sexually transmitted infections.
Microbix’s Multiplex Quality Control product offers several key benefits:
- Contain target pathogen’s whole genome
- Whole-process samples (including extraction)
- Inactivated to meet clinical laboratory biosafety requirements
- Commutable and cross-platform compatible
- Stable at 2-8°C; 1mL vials
- Verified performance on leading IVD platforms
As the incidence of STIs continues to rise globally, accurate and reliable diagnostic testing will only become more critical, making Microbix’s product an invaluable tool for healthcare providers.
Contact us to learn more about our FLOQ ® Swabs